![]() Array BioPharma Array BioPharma is focused on the discovery, development and commercialization of targeted small molecule drugs to treat patients afflicted with cancer. | ![]() Avid Bioservices Avid Bioservices, formerly Peregrine Pharmaceuticals, is a biopharmaceutical company. | ![]() Amicus Therapeutics Amicus Therapeutics is a biopharmaceutical company developing therapies for the treatment of rare and orphan diseases. | |
Founding Date | Founding Date 1998 | Founding Date 1981 | Founding Date 2002 |
Type | Type Subsidiary | Type Public | Type Public |
Tags | |||
Locations | Locations Boulder, US HQ Chicago, US Detroit, US Houston, US Miami, US New York, US Phoenix, US | Locations Tustin, US HQ | Locations Philadelphia, US HQ Northbridge, AU Pointe Claire, CA Paris, FR München, DE Dublin, IE Milano, IT see more |
Employees | Employees 110 | Employees 21114% increase | Employees 58415% increase |
Valuation ($) | Valuation ($) N/A | Valuation ($) 649.4 m | Valuation ($) 3.4 b |
Financial | |||
Revenue (est.) | Revenue (est.) $173.8m (FY, 2018) | Revenue (est.) $139.9m (FY, 2024) | Revenue (est.) $634.2m (FY, 2025) |
Cost of goods | Cost of goods $59.4m (FY, 2018) | Cost of goods $132.6m (FY, 2024) | Cost of goods $72.9m (FY, 2025) |
Gross profit | Gross profit $114.4m (FY, 2018) | Gross profit $7.3m (FY, 2024) | Gross profit $561.3m (FY, 2025) |
Net income | Net income ($147.7m) (FY, 2018) | Net income ($140.8m) (FY, 2024) | Net income ($27.1m) (FY, 2025) |

Avid Bioservices, formerly Peregrine Pharmaceuticals, is a biopharmaceutical company.
View company
Amicus Therapeutics is a biopharmaceutical company developing therapies for the treatment of rare and orphan diseases.
View company